Issue of colorectal cancer at the beginning of XXI century: achievements and prospects
Abstract
The aim of review. To analyze publications devoted to significant advances in treatment of colorectal cancer.
Key points. Essential successes in colorectal cancer treatment are determined: improvement of surgical technique, performance of total mesorectumectomy and expanded lymph node dissections, application of staplers at anterior rectectomy, laparoscopic surgery, improvement of radiation technique and its integration with chemotherapy, development and introduction of new chemotherapeutic agents, application of targeted therapy. Existing problems in treatment of colorectal cancer are determined: low rate of early stage detection, investigation and treatment of cancer patients by non-oncologist doctors, wide promotion of alternative medicine methods by mass media.
Conclusion. The further introduction of scientific advances in clinical practice, modernization of public health services will promote new achievements in treatment of colorectal cancer.
About the Author
O. I. Kit
Federal state-funded institution «Rostov Research Oncology Institute» Ministry of heathcare of the Russian Federation
Russian Federation
Russian Federation
Kit Oleg I. – MD, PhD, professor, director
344037. Rostov-on-Don, 14 liniya street, 63
References
1. Антониади Е.Г. Брифинг министра здравоохранения России В.И. Скворцовой (28.05.2012) // Доктор.Ру. № 5 (73). – 2012. – С. 6, 50–51.
2. Барсуков Ю.А., Николаев А.В., Тамразов Р.И., Ткачев С.И. Сравнительный анализ хирургического и комбинированного лечения больных операбельным раком прямой кишки (результаты рандомизированного исследования) // Практическая онкология. – 2002. – Т. 3, № 2. – С. 105–113.
3. Бердов Б.А., Цыб А.Ф., Юрченко Н.И. Диагностика и комбинированное лечение рака прямой кишки. – М.: Медицина, 1986. – С. 271.
4. Водовозова Е.Л., Кузнецова Н.Р., Моисеева Е.В. и др. Противоопухолевые липосомы с липофильными пролекарствами и углеводным лигандом селектинов // Материалы конф. «Нанотехнологии в онкологии 2010», 30 октября 2010, Москва. – М., 2010. – С. 37.
5. Воробьев Г.И., Шелыгин Ю.А., Фролов С.А. и др. Лапароскопические операции при колоректальных заболеваниях // Эндоскопическая хирургия – 1999. – № 5. – С. 65–66.
6. Гельперина C.Э., Халанский А.С., Швец В.И. Химиотерапия экспериментальной глиобластомы с помощью наносомальной формы доксорубицина // Материалы конф. «Нанотехнологии в онкологии 2010», 30 октября 2010, Москва. – М., 2010. – С. 41.
7. Давыдов М.И., Аксель Е.М. Злокачественные новообразования в России и странах СНГ в 2000 г. – М., 2002. – С. 14–32.
8. Сидоров Д.В. Роль тотальной мезоректумэктомии в хирургическом и комбинированном лечении больных раком прямой кишки: Автореф. дис. … д-ра мед. наук. – М., 2010. – С. 16–20.
9. Фролов С.А. Лапароскопические операции на прямой кишке: Автореф. дис. … д-ра мед. наук. – М., 2000. – 39 с.
10. Царьков П.В., Воробьев Г.И., Одарюк Т.С. Место и роль расширенной аорто-подвздошно-тазовой лимфаденэктомии в лечении рака нижнеампулярного отдела прямой кишки // Практическая онкология. – 2002. – Т. 3, № 2. – С. 82–92.
11. Чиссов В.И., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2010 году (заболеваемость и смертность). – М., 2012. – 260 с.
12. Шелыгин Ю.А., Воробьев Г.И., Фролов С.А. и др. Лапароскопические операции у больных раком прямой кишки // Практическая онкология. – 2002. – Т. 3, № 2. – С. 93–104.
13. Шелыгин Ю.А., Воробьев Г.И., Фролов С.А. Техника лапароскопических операций при раке толстой кишки // Практическая онкология. – 2005. – Т. 6, № 2. – С. 81–91.
14. Ajani J.A., Winter K.A., Gunderson L.L. et al. Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: a randomized controlled trial // JAMA. – 2008. – Vol. 199. – P. 1914–1921.
15. Artru J., Paye F., Louvet C. et al. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer; results of a phase II study // Proc. ASCO. – 2005. – Vol. 23, N3. – P. 502–509.
16. Buchs N.C., Allal A.S., Morel P., Gervaz P. Prevention, chemoradiation and surgery for anal cancer // Expert Rev. Anticancer Ther. – 2009. – Vol. 9. – P. 483–489.
17. Darzi A., Henry M.M., Guillou P.J. et al. Stapled laparoscopic rectopexy for rectal prolapsed // Surg. Endosc.
18. – 1995. – Vol. 9. – P. 301–303.
19. De Garamont A., Boni C., Navarro M. et al. Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: efficacy results with a median follow-up of 4 years // Proc. of the Gastrointestinal Cancers Symposium. – 2005. – Abstr. 3509.
20. Douillard J.Y., Cunningham D., Roth A.D. et al. Irinotecan combined with fluouracil compared with fluouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomized trial // Lancet. – 2000. – Vol. 355. – P. 1041.
21. Franklin M.E., Rosenthal D., Abrego-Medina D. et al. Prospective comparison of open vs. Laparoscopic colon surgery for carcinoma. Five-year results // Dis. Colon Rectum. – 1996. – Vol. 39. – P. 35–46.
22. Gastrointestinal Tumor Study Group (GITSG): Survival after postoperative combination treatment of rectal cancer // N. Engl. J. Med. – 1986. – Vol. 315. – P. 1294–1295.
23. Glass R., Ritchie J., Thompson H., Mann C. The results of surgical treatment of cancer of the rectum by radical resection and extended abdominoiliac lymphadenectomy // Br. J. Surg. – 1985. – Vol. 72. – P. 599–601.
24. Gorey T.F., O’Connell P.R., Waldron D. et al. Laparoscopic assisted reversal of Hartmann’s procedure // Br. J. Surg. – 1993. – Vol. 50. – P. 80–109.
25. Gray R.C., Barnwell J., Hills R. et al. QUASAR: A randomized study of adjuvant chemotherapy (CT) us observation including 3238 colorectal cancer patient // Proc. ASCO. – 2004. – P. 3501.
26. Hartley J.E., Mehigan B.J. et al. Total mesorectal excision: assessment of the laparoscopic approach // Dis. Colon Rectum. – 2001. – Vol. 44. – P. 315–321.
27. Hewett P.J., Allardyce R.A., Bagshaw P.F. et al. Short-term outcomes of the Australasian randomized clinical study comparing laparoscopic and conventional open surgical treatments for colon cancer: the ALCCas trial // Ann. Surg. – 2008. – Vol. 248. – P. 728–738.
28. Hida J., Yasutomi M., Fujimoto K. et al. Analysis of regional lymph node metastases from rectal carcinoma by the clearing method. Justification of the use of sigmoid in J-pouch construction after low anterior resection // Dis. Colon Rectum. – 1996. – Vol. 39, N 11. – P. 1282–1285.
29. Kohne C.H., Schoffski P., Wilke H. et al. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952 // Clin. Oncol. – 2003. – Vol. 21. – Р.9547–9549.
30. Krook J.E., Moertel C.G., Gunderson L.L. et al. Effective surgical adjuvant therspy for high-risk rectal carcinoma // N. Engl. J. Med. – 1991. – Vol. 324. – P. 709–715.
31. Labianca R., Nordlinger B., Beretta G.D. et al. Клинические рекомендации ESMO по необходимому уровню диагностики, адъювантной терапии и наблюдения при раке ободочной кишки // Минимальные клин. рек. Европейского об-ва мед. онкол. – М., 2010. – С. 110–118.
32. Moriya Y., Hojo K., Sawada T., Koyama Y. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection // Dis. Colon Rectum. – 1989. – Vol. 32. – P. 307–315.
33. MRC (Medical Research Council Rectal Cancer Working Party) // Lancet. – 1996. – Vol. 348. – P. 1610–1614.
34. Myerson R.J., Mohiudden M., Rich T.A. Rectal cancer // Clinical Radiation Oncology / Eds. Gunderson L.L., Tepper J.E. – N.Y.: Churchill Livingstone, 2000. – P. 728–747.
35. Nordlinger B., van Cutsem E., Gruenberger T. et al. European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel // Ann. Oncol. – 2009. – Vol. 20. – P. 985–992.
36. Radu C., Berglund A., Pahlman L., Glimelius B. Short course preoperative radiotherapy with delayed surgery in rectal cancer – a retrospective study // Radiother. Oncol. – 2008. – Vol. 87. – P. 343–349.
37. Regadas F.S.P., Ramos J.R., Souza J.V.S. et al. Laparoscopic colorectal procedure: a multicenter Brazilian experience // Surg. Laparosc. Endosc. – 1999. – Vol. 24. – P. 395–398.
38. Richard J. Heald, Brendan J. Moran, Roger D.H. et al. Rectal Cancer. The Basingstoke Experience of Total Mesorectal Excision, 1978–1997 // Arch. Syrg. – 1998. – Vol. 133 – P.894–898.
39. Salts L.B., Clarke S., Diaz-Rubio E. et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study // J. Clin. Oncol. – 2008. – Vol. 26. – P. 2013–2019.
40. Sebag-Montefiore D., Stephens R.J., Steele R. et al. Preoperative tadiotherapy versus selective postoperative chemotadiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomized trial // Lancet. – 2009. – Vol. 373. – P. 811–820.
41. Stocchi L., Nelson H., Young-Fadok T.M. et al. Safety and advantages of laparoscopic vs. open colectomy in the elderly. Mathed-Control study // Dis. Colon Rectum. – 2000. – Vol. 43. – P. 326–332.
42. Takahashi T., Veno M., Azekura K., Ota H. The lymphatic spread of rectal cancer and effect of dissection: Japanese contribution and experience // Soreide O., Norstein J. Rectal cancer surgery. – Berlin, Heidelberg: Springer-Verlag, 1997. – P. 164–180.
43. Tol J., Koopman M., Cats A. et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer // N. Engl. J. Med. – 2009. – Vol. 360. – P. 563–572.
44. Twelves C., Wong A., Nowacki M.P. et al. Capecitabine as adjuvant treatment for stage III colon cancer // N. Engl. J. Med. – 2005. – Vol. 352. – P. 2696–2704.
45. Vogel I., Soetc E., Ruder C. et al. Disseminated Tumor cells in the blood and/or bone marrow of patients with colorectal carcinoma are an independent prognostic factor // Ann. Oncol. – 2000. – Vol. 22. – P. 3508.
46. Wibe A., Moller B., Norstein J. et al. A national strategic change in treatment policy for rectal cancer – implementation of total mesorectal excision as routine treatment in Norway. A national audit // Dis. Colon Rectum. – 2002. – Vol. 45. – P. 857–866.
Review
For citations:
Kit O.I. Issue of colorectal cancer at the beginning of XXI century: achievements and prospects. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2013;23(3):65-71. (In Russ.)
Views:
95
Email this article 
